Incannex prices $12.5M private placement at $1.08/share to fund OSA trial

Incannex Healthcare Inc.

Gross proceeds $12.5M from 11.57M shares at $1.08 plus Series A warrants at $2.16.
Net proceeds ~$11.3M after placement agent fees and expenses.
Funds IHL-42X Phase 2/3 OSA study completion and Phase 3 expansion.
Proceeds also repay outstanding convertible debentures and for working capital.
Transaction closed March 10, 2025; R.F. Lafferty as sole placement agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.